Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J L BenoitP M Arnow

Abstract

We carried out an open, uncontrolled, prospective study to evaluate intraluminal antibiotic therapy for bloodstream infections arising from subcutaneously tunneled central venous catheters in patients receiving parenteral nutrition therapy at home. Seven bacterial infections were treated with intraluminal antibiotics (mean duration, 8.6 days) sometimes accompanied by systemic antibiotics (mean duration, 2.1 days). All seven infections were cured. Two infections caused by Candida species were treated with intraluminal amphotericin B. Fungal infections was suppressed during treatment but later relapsed, as confirmed by pulsed field DNA electrophoresis typing of bloodstream isolates. The concentration of antibiotic was assayed in intraluminal fluid from catheters of patients receiving treatment with vancomycin or gentamicin. The concentration was initially approximately 5 mg/mL, and it remained at > or = 2.5 mg/mL throughout the period that the solution was locked in the catheter. Our findings show that intraluminal therapy is effective against selected bacterial infections and can suppress fungal infections in subcutaneously tunneled catheters.

Citations

Jan 16, 2007·Langenbeck's Archives of Surgery·Eduardo E Montalvo-JaveMichael G Sarr
May 20, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A Sánchez-MuñozH Cortés-Funes
Nov 28, 2001·Current Infectious Disease Reports·Nasia SafdarDennis G. Maki
Jul 3, 1998·Gastroenterology Clinics of North America·L Howard, N Hassan
May 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P LonguetC Leport
Nov 3, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P VialeG Carosi
May 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher J Crnich, Dennis G Maki
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Jul 14, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nasia Safdar, Dennis G Maki
Mar 7, 2000·The Journal of Antimicrobial Chemotherapy·I Raad
Mar 12, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ali Mirza OnderGaston Zilleruelo
Aug 7, 2003·Journal of Pediatric Hematology/oncology·Claudia DannenbergDieter Körholz
Apr 16, 2004·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Holly Bagnall-Reeb
Aug 12, 2005·The Pediatric Infectious Disease Journal·Elio CastagnolaRaffaella Giacchino
Apr 29, 2006·The Pediatric Infectious Disease Journal·Philip Toltzis
Oct 17, 2012·Antimicrobial Agents and Chemotherapy·Carla J Walraven, Samuel A Lee
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Matthew K SchinabeckMahmoud A Ghannoum
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·John J Curtin, Rodney M Donlan
Sep 18, 2013·Critical Care : the Official Journal of the Critical Care Forum·Susanne JanumArash Afshari
Jun 10, 2004·The Tohoku Journal of Experimental Medicine·Serkan OncuSerhan Sakarya
Oct 1, 2004·Drugs·Stijn Blot, Koenraad Vandewoude
Sep 6, 2011·Emerging Infectious Diseases·Fadi Al AkhrassIssam Raad
Dec 24, 2013·International Journal of Antimicrobial Agents·Gordon RamageCraig Williams
Apr 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L A MermelUNKNOWN Society for Healthcare Epidemiology of America
Jan 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of Americaa
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of America
Jun 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Leonard A MermelDavid K Warren
Dec 7, 2013·Expert Review of Anti-infective Therapy·Nuria Fernández-Hidalgo, Benito Almirante
Jul 23, 2004·Expert Opinion on Investigational Drugs·Rebekah R ArthurJohn R Perfect
Apr 6, 2004·Journal of Vascular and Interventional Radiology : JVIR·Keri Hall, Barry Farr
Dec 7, 2010·International Journal of Antimicrobial Agents·Leonidia Leonidou, Charalambos A Gogos
Nov 2, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J Carratalà
May 5, 2009·Enfermedades infecciosas y microbiología clínica·José Antonio Morales-MolinaPedro Acosta
Oct 19, 2005·The Journal of Infection·A Angel-MorenoJ L Pérez Arellano
Nov 30, 2006·Journal of Chemotherapy·P Viale, S Stefani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
E A KrzywdaE J Quebbeman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
P DomingoG Vazquez
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
P VialeG Carosi
© 2021 Meta ULC. All rights reserved